| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | $0-100.0% | $1.7M-78.4% | $7.7M-98.9% | $698.8M+29.7% | $538.6M+41.4% | $380.8M+24.0% | $307.0M+16.0% | $264.7M | — |
| Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets | $47.0M-18.1% | $57.4M-12.4% | $65.5M | — | — | — | — | — | — |
| Amortization of acquired intangible assets | $24.7M-59.3% | $60.7M-72.7% | $222.6M+91.0% | $116.6M+112.9% | $54.8M+48.4% | $36.9M+33.4% | $27.6M+20.9% | $22.9M+48.7% | $15.4M |
| Research and development | $455.2M-14.8% | $534.5M-19.8% | $666.6M+2.3% | $651.5M+20.5% | $540.7M+13.2% | $477.6M+85.5% | $257.5M+49.7% | $172.0M+46.4% | $117.5M |
| Selling, general and administrative | $347.1M+15.4% | $300.9M-9.5% | $332.5M+2.0% | $326.0M+14.1% | $285.8M+16.6% | $245.2M+21.0% | $202.5M+31.9% | $153.5M+26.6% | $121.3M |
| Change in the fair value of contingent consideration | -$800K+82.1% | -$4.5M+96.5% | -$127.7M-393.1% | -$25.9M-5080.0% | -$500K-102.1% | $23.3M-51.9% | $48.4M+150.1% | $19.3M | $0 |
| Intangible asset impairment | $159.5M-26.7% | $217.8M | — | $33.4M | — | — | — | — | — |
| Tangible asset impairment and (gains) losses on transactions, net | -$9.6M-1383.6% | $750K | — | — | — | — | — | — | — |
| Total operating expenses | $863.7M-22.1% | $1.11B-19.5% | $1.38B+20.2% | $1.15B+25.5% | $913.0M+12.4% | $812.5M+48.2% | $548.1M+44.1% | $380.4M+47.1% | $258.7M |
| Income (loss) from operations | $866.9M+386.5% | -$302.6M+31.2% | -$439.5M+1.8% | -$447.4M-19.5% | -$374.4M+13.3% | -$431.8M-79.0% | -$241.2M-108.5% | -$115.7M-79.9% | -$64.3M |
| Interest expense, net | -$152.2M+8.8% | -$167.0M-29.3% | -$129.2M-42.2% | -$90.9M-5.6% | -$86.0M-52.7% | -$56.4M-351.1% | -$12.5M+0.5% | -$12.6M-3.8% | -$12.1M |
| Other (expense) income, net | -$18.1M-376.4% | $6.5M-35.4% | $10.1M+120.6% | -$49.2M+15.0% | -$57.9M-167.9% | $85.2M+520.8% | $13.7M+10538.0% | $129K+110.1% | -$1.3M |
| Gain on sale of priority review voucher | $99.9M | — | — | — | — | — | — | — | — |
| Loss on extinguishment of debt | -$137.6M | — | — | — | — | — | — | — | — |
| Income (loss) before income tax (expense) benefit | $696.6M+291.8% | -$363.1M+47.8% | -$696.1M-18.5% | -$587.5M-13.3% | -$518.3M-28.6% | -$402.9M-67.9% | -$239.9M-87.3% | -$128.1M-65.0% | -$77.7M |
| Income tax (expense) benefit | -$14.0M-7840.3% | -$176K-100.3% | $69.5M+144.1% | $28.5M+612.0% | -$5.6M+84.2% | -$35.2M-202.4% | -$11.7M-40272.4% | $29K+102.2% | -$1.3M |
| Net income (loss) attributable to common stockholders | $682.6M+287.9% | -$363.3M+42.0% | -$626.6M-12.1% | -$559.0M-6.7% | -$523.9M-19.6% | -$438.2M-74.2% | -$251.6M-96.4% | -$128.1M-62.1% | -$79.0M |
| Basic (in shares) | 79.53B+3.5% | 76.85B+2.7% | 74.84B+104235.3% | 71.7M-99.9% | 70.47B+6.7% | 66.03B+12.2% | 58.86B | — | — |
| Diluted (in shares) | 88.31B+14.9% | 76.85B+2.7% | 74.84B+104235.3% | 71.7M-99.9% | 70.47B+6.7% | 66.03B+12.2% | 58.86B | — | — |
| Basic | $9K+281.4% | -$5K+43.5% | -$8K-107345.4% | -$7.79+99.9% | -$7K-11.9% | -$7K-55.5% | -$4K | — | — |
| Diluted | $8K+264.5% | -$5K+43.5% | -$8K-107345.4% | -$7.79+99.9% | -$7K-11.9% | -$7K-55.5% | -$4K | — | — |
| Net product revenue | |||||||||
| Collaboration and license revenue | |||||||||
| Royalty revenue | |||||||||
| Translarna | |||||||||
| Manufacturing revenue | |||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.